DUBLIN–(BUSINESS WIRE)–The “Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2030” report has been added to ResearchAndMarkets.com…
Author: Business Wire
Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products
NASHVILLE, Tenn. & TORONTO–(BUSINESS WIRE)—- $HROW–Harrow, Inc. (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, and Apotex Inc. (“Apotex”), Canada’s largest pharmaceutical company, today jointly announced an exclusive out-licensing a…
Advancing Clinical Excellence: 20/20 Onsite Life Sciences Clinic Managers Achieve Prestigious Certified Paraoptometric Status
BOSTON–(BUSINESS WIRE)–20/20 Onsite Life Sciences Clinic Managers Achieve Prestigious Certified Paraoptometric Status.
EyeBio Announces Positive Visual, Anatomic and Safety Data from First-in-Human Ph1b/2a AMARONE Trial of Restoret at Macula Society Annual Meeting
NEW YORK & LONDON–(BUSINESS WIRE)–EyeBio announced the presentation of Week 12 data from its first-in-human Phase 1b/2a AMARONE trial of Restoret in individuals with DME and NVAMD.
National Vision Holdings, Inc. Announces Fourth Quarter and Fiscal 2023 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its fourth quarter and fiscal 2023 financial results before the market opens on Tuesday, February 27, 2024. The Company will hos…
Former CooperVision Leader Tom Bender Joins MediPrint Ophthalmics as Strategic Advisor
SAN DIEGO–(BUSINESS WIRE)– #DrugElutingLenses–Tom Bender, former CooperVision exec, joins MediPrint Ophthalmics as an advisor for innovative drug-delivering contact lenses.
Warby Parker to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and full year ended December 31, 2023 will be r…
Precision Optic Market Report 2024: Rising Demand in Medical and Automotive Sectors Drives Growth – Global Trends, Forecast and Competitive Analysis to 2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Precision Optic Market Report: Trends, Forecast and Competitive Analysis to 2030” report has been added to ResearchAndMarkets.com’s offering. The global Precision optic market is expected to reach an estimated $51.2 billio…
National Vision Appoints Susan O’Farrell to Board of Directors
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE), the nation’s second largest optical retailer providing quality, affordable eye care and eyewear, announced today the appointment of Susan O’Farrell to its Board of Directors an…
Baxter Reports Fourth-Quarter and Full-Year 2023 Results
DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2023, and provided its financial guidance for full-year and first-quarter 2024. …
MMRG Notifies Patients of Cybersecurity Incident
TEMPE, Ariz.–(BUSINESS WIRE)–Medical Management Resource Group, L.L.C. (“MMRG” or the “Company”, d.b.a. American Vision Partners, www.americanvisionpartners.com), which provides administrative services to ophthalmology practices, today provided notic…
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
TUCSON, Ariz.–(BUSINESS WIRE)—- $BRKR #BRKR–Bruker Corporation (Nasdaq: BRKR) today announced that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems. This acquisition fills a gap in the techno…
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2023 financial results on Wednesday,…
Samenvatting: Toku ontvangt CE- en UKCA-keurmerken voor AI-beoordelingen van cardiovasculaire risico's via het oog
SAN DIEGO–(BUSINESS WIRE)–Toku, Inc., een commercieel bedrijf dat medische hulpmiddelen produceert en gespecialiseerd is in AI-beoordeling van netvliesbeelden, maakte vandaag bekend dat het de CE- en UKCA-keurmerken heeft verkregen voor haar gepatent…
Toku obtient les marquages CE et UKCA pour l'évaluation du risque cardiovasculaire par IA à travers l'œil
SAN DIEGO–(BUSINESS WIRE)–Toku, Inc., une entreprise commerciale spécialisée dans l’évaluation par IA d’images rétiniennes, a annoncé aujourd’hui qu’elle a obtenu les marquages CE et UKCA pour sa technologie brevetée CLAiR. Cette étape importante sou…
Thought Leadership & Innovation Foundation Announces Strategic Partnership with American Macular Degeneration Foundation, Debuts Patient Testimonial Video Featuring TLI Fellow
McLEAN, Va.–(BUSINESS WIRE)–Thought Leadership & Innovation Foundation (TLI), a not-for-profit organization that works at the nexus of science, technology and public health, today announces a strategic partnership with the American Macular Degene…
Riassunto: Toku ottiene la marcatura CE e UKCA per valutare il rischio di sviluppare malattie cardiache, utilizzando una scansione della retina
SAN DIEGO–(BUSINESS WIRE)–Toku, Inc., società di dispositivi medici commerciali specializzata nella valutazione IA delle immagini retiniche, ha annunciato oggi di aver ottenuto la marcatura CE e UKCA per la sua tecnologia brevettata CLAiR. Il testo o…
Resumen: Toku obtiene las marcas CE y UKCA para evaluar el riesgo cardiovascular a través del ojo con ayuda de la IA
SAN DIEGO–(BUSINESS WIRE)–Toku, Inc., empresa comercial de dispositivos médicos especializada en la evaluación de imágenes retinianas mediante IA, ha anunciado hoy la obtención de las marcas CE y UKCA para su tecnología patentada CLAiR. El comunicado…
Toku erhält CE- und UKCA-Zeichen für kardiovaskuläre Risikobewertungen mit KI durch das Auge
SAN DIEGO–(BUSINESS WIRE)–Toku, Inc., ein kommerzielles Medizintechnikunternehmen, das sich auf die KI-Auswertung von Netzhautbildern spezialisiert hat, gab heute bekannt, dass es die CE- und UKCA-Zeichen für seine patentierte CLAiR-Technologie erhal…
Toku Obtains CE and UKCA Marks for AI Cardiovascular Risk Assessments Through the Eye
SAN DIEGO–(BUSINESS WIRE)–Toku, Inc., a commercial medical device company specializing in AI assessment of retinal images, announced today that it has obtained CE and UKCA Marks for its patented CLAiR technology. This significant milestone underscore…